tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Ratios

Compare
300 Followers

Neuphoria Therapeutics Ratios

NEUP's free cash flow for Q2 2026 was AU$0.00. For the 2026 fiscal year, NEUP's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
9.04 3.56 3.45 4.87 12.46
Quick Ratio
9.04 3.56 3.45 4.87 12.46
Cash Ratio
8.57 3.37 3.29 4.42 10.00
Solvency Ratio
-54.09 0.03 -2.19 -4.42 -3.77
Operating Cash Flow Ratio
28.92 12.04 -3.83 -5.40 -6.48
Short-Term Operating Cash Flow Coverage
1.49K 1.55K -443.27 -100.57 0.00
Net Current Asset Value
AU$ 16.49MAU$ 8.29MAU$ 3.04MAU$ 4.13MAU$ 22.99M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 0.02 0.02 0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.02 0.02 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.23 1.50 1.58 1.32 1.15
Debt Service Coverage Ratio
-7.56K 9.02 -670.31 -214.25 -1.18K
Interest Coverage Ratio
0.00 0.00 0.00 0.00 -1.55K
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.00
Interest Debt Per Share
0.01 0.14 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.03 79.71 0.55 0.36 0.81
Profitability Margins
Gross Profit Margin
94.74%95.76%0.00%0.00%0.00%
EBIT Margin
-101.35%-5.35%0.00%0.00%-10506.50%
EBITDA Margin
-10321.04%-1.12%0.00%0.00%-10085.68%
Operating Profit Margin
-13728.73%-7.21%0.00%0.00%-10292.00%
Pretax Profit Margin
-10250.46%-5.35%0.00%0.00%-10523.25%
Net Profit Margin
-4546.55%-2.36%0.00%0.00%-8253.62%
Continuous Operations Profit Margin
-4546.55%-2.36%0.00%0.00%-8253.62%
Net Income Per EBT
44.35%44.11%99.44%97.44%78.43%
EBT Per EBIT
74.66%74.22%87.07%99.82%102.25%
Return on Assets (ROA)
-1020.11%-1.30%-83.88%-111.62%-51.05%
Return on Equity (ROE)
-1538.29%-1.96%-132.61%-147.75%-58.58%
Return on Capital Employed (ROCE)
-3315.06%-4.67%-112.45%-126.66%-67.11%
Return on Invested Capital (ROIC)
-1468.15%-2.05%-111.10%-122.74%-52.50%
Return on Tangible Assets
-1596.38%-2.46%-171.92%-227.24%-78.26%
Earnings Yield
-1789.19%-4.91%-1.87%-0.45%-0.24%
Efficiency Ratios
Receivables Turnover
4.94 0.00 0.00 0.00 0.06
Payables Turnover
1.40 0.58 0.44 0.70 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 149.60 0.00 0.00 0.60
Asset Turnover
0.22 0.55 0.00 0.00 <0.01
Working Capital Turnover Ratio
0.55 1.86 0.00 0.00 0.01
Cash Conversion Cycle
-186.44 -630.95 -825.20 -520.83 6.13K
Days of Sales Outstanding
73.91 0.00 0.00 0.00 6.13K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
260.35 630.95 825.20 520.83 0.00
Operating Cycle
73.91 0.00 0.00 0.00 6.13K
Cash Flow Ratios
Operating Cash Flow Per Share
16.49 47.59 -0.10 -0.08 -0.13
Free Cash Flow Per Share
16.49 47.59 -0.10 -0.08 -0.13
CapEx Per Share
<0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
24.93M 0.00 0.00 -39.43M -14.09K
Capital Expenditure Coverage Ratio
24.93M 0.00 0.00 -39.43M -14.09K
Operating Cash Flow Coverage Ratio
1.49K 340.99 -53.83 -38.23 -31.37
Operating Cash Flow to Sales Ratio
9.11 3.22 0.00 0.00 -53.85
Free Cash Flow Yield
864.84%670.23%-1.18%-0.20%-0.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.06 -20.37 -53.48 -224.01 -412.44
Price-to-Sales (P/S) Ratio
1.06 0.48 0.00 0.00 34.04K
Price-to-Book (P/B) Ratio
0.71 0.40 70.92 330.97 241.63
Price-to-Free Cash Flow (P/FCF) Ratio
0.12 0.15 -84.49 -492.49 -632.06
Price-to-Operating Cash Flow Ratio
0.28 0.15 -84.49 -492.49 -632.10
Price-to-Earnings Growth (PEG) Ratio
>-0.01 -0.16 1.30 -7.28 -13.75
Price-to-Fair Value
0.71 0.40 70.92 330.97 241.63
Enterprise Value Multiple
0.02 36.72 -54.99 -224.71 -336.72
Enterprise Value
-13.47M -9.84M 1.23B 4.84B 9.44B
EV to EBITDA
0.02 36.72 -54.99 -224.71 -336.72
EV to Sales
-1.64 -0.41 0.00 0.00 33.96K
EV to Free Cash Flow
-0.18 -0.13 -83.65 -491.70 -630.55
EV to Operating Cash Flow
-0.18 -0.13 -83.65 -491.70 -630.59
Tangible Book Value Per Share
3.64 5.20 0.02 0.04 0.21
Shareholders’ Equity Per Share
6.55 17.79 0.12 0.12 0.35
Tax and Other Ratios
Effective Tax Rate
0.56 0.56 <0.01 0.03 0.22
Revenue Per Share
1.81 14.76 0.00 0.00 <0.01
Net Income Per Share
-82.30 -0.35 -0.15 -0.18 -0.20
Tax Burden
0.44 0.44 0.99 0.97 0.78
Interest Burden
101.14 1.00 1.00 1.00 1.00
Research & Development to Revenue
1.10K 0.58 0.00 0.00 60.69
SG&A to Revenue
946.55 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
19.96 6.84 0.00 0.00 7.00
Income Quality
-0.20 -0.21 0.95 0.68 1.00
Currency in AUD